Buscar
01/05/2024
Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Drozd-Sokolowska, J, Gras, L, Koster, L, Martino, R, Salas, MQ, Salmenniemi, U, Zudaire, T, Yañez, L, Bellido, M, Collin, M, Kaufmann, M, Kozlowski, P, Poiré, X, Ferra, C, Sampol, A, Wilson, KMO, Cairoli, A, Gedde-Dahl, T, Deconinck, E, Mirabile, M, Suarez, F, Raj, K, van Gelder, M, Yakoub-Agha, I, Tournilhac, O, Mclornan, DP. Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT. HAEMATOLOGICA. 2024; 109(5)DOI:10.3324/haematol.2023.284359. PMID:38205539. IF:10.100(Q1/2D).
01/12/2023
Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/GETH Study
Bastos-Oreiro M., Gutierrez A., Iacoboni G., López Corral L., Reguera J.L., Abrisqueta P., Delgado J., Terol M.J., Hernani R., Martínez N., Ortíz V., Bailen R., Gomez-Centurión I., Caballero A., Sanz J., Guerra Domínguez L., Luzardo H., Mussetti A., Jiménez-Ubieto A., Sancho J.M., Sureda A., Pérez A., Barba P., Kwon M., Martín García-Sancho A.. Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/GETH Study. Transplantation And Cellular Therapy. 2023; 29(12)DOI:10.1016/j.jtct.2023.08.026. PMID:37659694. IF:3.600(Q1/3D).
01/12/2023
Secreted Protein Acidic and Rich in Cysteine (SPARC) Polymorphisms in Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer Patients
Arqueros, C, Salazar, J, Gallardo, A, Andrés, M, Tibau, A, Bell, OL, Artigas, A, Lasa, A, Cajal, T, Lerma, E, Barnadas, A. Secreted Protein Acidic and Rich in Cysteine (SPARC) Polymorphisms in Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer Patients. Biomedicines. 2023; 11(12)DOI:10.3390/biomedicines11123231. PMID:38137452. IF:3.900(Q1/3D).
16/11/2023
Outcome improvement over time in reduced intensity conditioning hematopoietic transplantation: a 20-year experience
Esquirol, A, Cadenas, IG, Novelli, S, Garrido, A, Caballero, AC, Oñate, G, Lopez, J, Redondo, S, Argüello, M, Saavedra, S, Moreno, C, Briones, J, Sierra, J, Martino, R. Outcome improvement over time in reduced intensity conditioning hematopoietic transplantation: a 20-year experience. ANNALS OF HEMATOLOGY. 2023; 103(1)DOI:10.1007/s00277-023-05530-w. PMID:37971549. IF:3.000(Q2/4D).